Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.712
-0.008 (-1.17%)
At close: Dec 20, 2024, 4:00 PM
0.730
+0.018 (2.59%)
After-hours: Dec 20, 2024, 7:58 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $31.06 million as of December 20, 2024. Its market cap has decreased by -50.35% in one year.
Market Cap
31.06M
Enterprise Value
26.68M
1-Year Change
-50.35%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $31.06M, a decrease of -64.97%. That is a compound annual growth rate of -26.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 31.06M | -63.33% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 32.74M |
| NeueHealth | 32.60M |
| Cumberland Pharmaceuticals | 32.58M |
| Surrozen | 32.08M |
| Incannex Healthcare | 31.49M |
| Chemomab Therapeutics | 30.55M |
| Nortech Systems | 30.46M |
| Intensity Therapeutics | 30.20M |